Immunotherapy

Immunotherapy is the concept of using the immune system to treat disease, for example, developing a vaccine against cancer. Immunotherapy may also refer to the therapy of diseases caused by the immune system, allergies for example.
What is Immunotherapy?

Immunotherapy is a treatment that is designed to harness the ability of the body’s immune system to combat infection or disease.

Read More

Overview

Feature Articles

Latest Immunotherapy News and Research

Study of immunotherapy for brain cancer metastases shows promising results

Study of immunotherapy for brain cancer metastases shows promising results

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

High levels of memory killer cells correlate with better survival in melanoma patients

High levels of memory killer cells correlate with better survival in melanoma patients

NCI launches new initiative to test new drug combinations that target specific tumor alterations

NCI launches new initiative to test new drug combinations that target specific tumor alterations

Increased risk of cardiovascular disease in psoriatic arthritis patients

Increased risk of cardiovascular disease in psoriatic arthritis patients

Novel approach improves the efficacy of immune checkpoint blockade and minimizes related side effects

Novel approach improves the efficacy of immune checkpoint blockade and minimizes related side effects

Scientists develop new immuno-therapeutic approach to target brain metastatic melanomas

Scientists develop new immuno-therapeutic approach to target brain metastatic melanomas

New pan-cancer T cell atlas provides a deeper understanding of complex tumor microenvironment

New pan-cancer T cell atlas provides a deeper understanding of complex tumor microenvironment

2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

Using nanoparticles and magnetic field to guide immunotherapy cells

Using nanoparticles and magnetic field to guide immunotherapy cells

Case study: Experimental lecanemab treatment causes adverse outcomes in 65-year-old woman with Alzheimer's disease

Case study: Experimental lecanemab treatment causes adverse outcomes in 65-year-old woman with Alzheimer's disease

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Cancer researchers join together to fight lethal childhood brain cancer

Cancer researchers join together to fight lethal childhood brain cancer

The role of RNA splicing in one of the deadliest forms of pancreatic cancer

The role of RNA splicing in one of the deadliest forms of pancreatic cancer

Researchers receive $2.3 million to continue development of a new ‘glyco-immune’ checkpoint inhibitor

Researchers receive $2.3 million to continue development of a new ‘glyco-immune’ checkpoint inhibitor

Novel computational platform can expand the pool of cancer immunotherapy targets

Novel computational platform can expand the pool of cancer immunotherapy targets

Researchers discover key epigenetic alteration associated with clinical course of liver cancer

Researchers discover key epigenetic alteration associated with clinical course of liver cancer

Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

Clinical trial of a combination treatment shows great promise for patients with glioblastoma

Clinical trial of a combination treatment shows great promise for patients with glioblastoma